Table of Contents
ISLAMABAD: Pakistan has officially become the second country in the Eastern Mediterranean Region to join the Global Platform for Access to Childhood Cancer Medicines, a joint initiative by the World Health Organization (WHO) and St. Jude Children’s Research Hospital. The move is a significant step in improving access to life-saving cancer treatments for children in Pakistan.
The agreement, signed by Federal Health Minister Syed Mustafa Kamal and WHO Representative in Pakistan Dr. Dapeng Luo, is valid until December 31, 2027, and may be extended through mutual consent.
Aiming to Double Survival Rate by 2030
The platform’s primary goal is to close the treatment gap that currently affects more than half of the children diagnosed with cancer in Pakistan. The program seeks to raise the national survival rate from 30% to 60% by 2030—a milestone that aligns with global goals for pediatric oncology.
In higher-income countries, survival rates for childhood cancer hover around 80%, while low- and middle-income nations like Pakistan struggle due to limited treatment availability and unaffordable medicine costs.
PAF Pilot Accuses Woman of Blackmail After Refusing Marriage Proposal
Over 8,000 Children to Benefit Annually
Under the agreement, Pakistan will gain free access to quality-assured cancer medicines for more than 8,000 children diagnosed with cancer every year. These drugs will be procured and delivered by UNICEF, ensuring uninterrupted supply and adherence to international quality standards.
“This is a landmark moment for Pakistan,” said Health Minister Kamal. “Through this agreement, we secure essential medicines for our young cancer warriors. If even one child’s life is saved through this collaboration, we are saving humanity.”
Platform Backed by Global Institutions
The Global Platform, launched in 2021, is a collaborative effort between WHO, St. Jude Children’s Research Hospital, and UNICEF to assist low- and middle-income countries in gaining access to certified cancer medications. The initiative not only tackles pharmaceutical supply but also provides technical expertise and operational support.
In Pakistan’s case, WHO will continue working closely with federal and provincial health departments, strengthening diagnostic services, treatment protocols, and long-term care.
Healthcare Equity for Children
Experts say that this program marks a crucial stride toward health equity, ensuring that no child is denied treatment due to financial constraints or system inefficiencies. The inclusion of Pakistan in the platform also sets a precedent for other regional countries to follow suit.
“This partnership will support Pakistan in building a resilient and equitable health system for children with cancer,” said Dr. Dapeng Luo. “It is not just about medicine—it’s about giving hope.”
Conclusion
As Pakistan joins the global fight against childhood cancer, this agreement with WHO and its partners symbolizes a transformative health milestone. With dedicated resources, expert support, and global solidarity, the country is poised to offer better survival prospects to thousands of young patients—and a renewed promise of life.
